Researchers at Imperial College London have shown that a toxin from the Peruvian green velvet tarantula was able to alleviate pain.
U.S. regulators approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.
Sanford Health added to its growing international portfolio by acquiring a minority stake in Isar Klinikum, a hospital based in Munich. Sanford plans to work intimately with the German hospital on stem cell therapy.
The blue agave plant is already being investigated as the source of treatments for osteoporosis and lowering blood glucose, and now is being used as the raw material in a bio-skin to treat second-and third-degree burns.
A Silicon Valley innovation company is coming to Cleveland Clinic to create an accelerator focused on biotech and digital health innovation.
A research team from Queen Mary University of London developed a very fast dissolving "bioactive" glass that can be used in toothpaste or dental fillings to repair decayed teeth.
A new study in Scientific Reports finds that microscopic particles from tattoo ink can migrate into the lymph nodes.
Federal regulators have approved the first continuous blood sugar monitor for diabetics that doesn't need backup finger prick tests.
Once a year scientists gather in Boston to celebrate the quirky and absurd in science at the Ig Nobel ceremony. This year they awarded a prize to research that playing the didgeridoo helps relieve sleep apnea.
A new study looks at whether testosterone directly affects decisions that drive up prices and destabilize markets.
A research team from Harvard have identified bacteria in the microbiome of exceptional athletes that could help with athletic performance and recovery.
The cobwebs you swat away in your attic may have found a higher purpose: raw material for new cardiac tissue.